These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27752142)

  • 1. Systems genetics analysis of pharmacogenomics variation during antidepressant treatment.
    Madsen MB; Kogelman LJA; Kadarmideen HN; Rasmussen HB
    Pharmacogenomics J; 2018 Jan; 18(1):144-152. PubMed ID: 27752142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.
    Biernacka JM; Sangkuhl K; Jenkins G; Whaley RM; Barman P; Batzler A; Altman RB; Arolt V; Brockmöller J; Chen CH; Domschke K; Hall-Flavin DK; Hong CJ; Illi A; Ji Y; Kampman O; Kinoshita T; Leinonen E; Liou YJ; Mushiroda T; Nonen S; Skime MK; Wang L; Baune BT; Kato M; Liu YL; Praphanphoj V; Stingl JC; Tsai SJ; Kubo M; Klein TE; Weinshilboum R
    Transl Psychiatry; 2015 Apr; 5(4):e553. PubMed ID: 25897834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
    Yin L; Zhang YY; Zhang X; Yu T; He G; Sun XL
    Pharmacopsychiatry; 2015 May; 48(3):95-103. PubMed ID: 25642918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence.
    Zhu J; Klein-Fedyshin M; Stevenson JM
    Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic prediction of antidepressant drug response and nonresponse in Korean patients.
    Lim SW; Won HH; Kim H; Myung W; Kim S; Kim KK; Carroll BJ; Kim JW; Kim DK
    PLoS One; 2014; 9(9):e107098. PubMed ID: 25226239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.
    Ji Y; Biernacka J; Snyder K; Drews M; Pelleymounter LL; Colby C; Wang L; Mrazek DA; Weinshilboum RM
    Pharmacogenomics J; 2012 Feb; 12(1):78-85. PubMed ID: 20877297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of single nucleotide polymorphism of D2 dopamine receptor gene on major depressive disorder and response to antidepressant treatment.
    Wang Y; Liu X; Yu Y; Han Y; Wei J; Collier D; Li T; Ma X
    Psychiatry Res; 2012 Dec; 200(2-3):1047-50. PubMed ID: 22796099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the TPH1 A218C polymorphism and antidepressant response: evidence from an updated ethnicity, antidepressant-specific, and ethnicity-antidepressant interaction meta-analysis.
    Zhao X; Huang Y; Li D; Han C; Kan Q
    Psychiatr Genet; 2015 Feb; 25(1):1-8. PubMed ID: 25419635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
    Srivastava A; Singh P; Gupta H; Kaur H; Kanojia N; Guin D; Sood M; Chadda RK; Yadav J; Vohora D; Saso L; Kukreti R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
    Dreimüller N; Tadić A; Dragicevic A; Boland K; Bondy B; Lieb K; Laux G; Maier W; Müller MJ; Rao ML; Rietschel M; Röschke J; Zill P; Hiemke C
    Pharmacopsychiatry; 2012 May; 45(3):108-13. PubMed ID: 22086748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics.
    Ji Y; Biernacka JM; Hebbring S; Chai Y; Jenkins GD; Batzler A; Snyder KA; Drews MS; Desta Z; Flockhart D; Mushiroda T; Kubo M; Nakamura Y; Kamatani N; Schaid D; Weinshilboum RM; Mrazek DA
    Pharmacogenomics J; 2013 Oct; 13(5):456-63. PubMed ID: 22907730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
    Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ; Hou SJ; Yen FC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):637-41. PubMed ID: 19272410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis.
    Woo HI; Lim SW; Myung W; Kim DK; Lee SY
    Exp Mol Med; 2018 Aug; 50(8):1-11. PubMed ID: 30076325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.
    Gupta M; Neavin D; Liu D; Biernacka J; Hall-Flavin D; Bobo WV; Frye MA; Skime M; Jenkins GD; Batzler A; Kalari K; Matson W; Bhasin SS; Zhu H; Mushiroda T; Nakamura Y; Kubo M; Wang L; Kaddurah-Daouk R; Weinshilboum RM
    Mol Psychiatry; 2016 Dec; 21(12):1717-1725. PubMed ID: 26903268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4.
    Nonen S; Kato M; Takekita Y; Wakeno M; Sakai S; Serretti A; Kinoshita T
    J Clin Psychopharmacol; 2016 Feb; 36(1):27-31. PubMed ID: 26674707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.
    Fabbri C; Minarini A; Niitsu T; Serretti A
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1093-118. PubMed ID: 24930681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.